Concepedia

MARY E. VALIANT

ME

6

Publications

179

Citations

6

H-Index

1976

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MARY E. VALIANT is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in microbiology, medicine, and antimicrobial resistance.

Top concepts

Publications per year

1976–1989

6

Publications

6

GELRITE as an Agar Substitute in Bacteriological Media

D L Shungu, MARY E. VALIANT, Vicki Tutlane et al. · Applied and Environmental Microbiology · 1983 · 103 citations · Full text

, , +8

Antibacterial activity of efrotomycin.

Bettina M. Frost, MARY E. VALIANT, Barbara Weissberger et al. · The Journal of Antibiotics · 1976 · 24 citations · Full text

Antibacterial activities of fluorovinyl- and chlorovinylglycine and several derived dipeptides

Arthur A. Patchett, D. Taub, Barbara Weissberger et al. · Antimicrobial Agents and Chemotherapy · 1988 · 15 citations · Full text

, , +12

Antibacterial activity of heneicomycin.

Bettina M. Frost, MARY E. VALIANT, Eugene L. Dulaney · The Journal of Antibiotics · 1979 · 14 citations · Full text

L-658,310, a new injectable cephalosporin. I. In vitro antibacterial properties.

Barbara Weissberger, George K. Abruzzo, Robert A. Fromtling et al. · The Journal of Antibiotics · 1989 · 13 citations · Full text

Rows per page

1–5 of 6